Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rickenbach

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
BMJ (Clinical Research Ed.)|December 11, 1997
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort StudyM Egger, B Hirschel, P Francioli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Importance of mental health assessment in HIV-infected outpatientsC Zinkernagel, P Taffé, M Rickenbach, et al.
Swiss Medical Weekly|February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in SwitzerlandK Overbeck, J F Dufour, B Müllhaupt, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
British Journal of Cancer|July 31, 2008
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyS Franceschi, L Dal Maso, M Rickenbach, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
BMJ (Clinical Research Ed.)|December 11, 1997
Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort StudyM Egger, B Hirschel, P Francioli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 9, 1999
Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort StudyS Bassetti, M Battegay, H Furrer, et al.
HIV Medicine|April 16, 2008
Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort StudyM Wolbers, H C Bucher, H Furrer, et al.
Swiss Medical Weekly|October 20, 2001
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapyM Rossi, M Flepp, A Telenti, et al.
AIDS (London, England)|March 10, 2001
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre studyH Furrer, M Opravil, M Rossi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 6, 2001
Importance of mental health assessment in HIV-infected outpatientsC Zinkernagel, P Taffé, M Rickenbach, et al.
Swiss Medical Weekly|February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in SwitzerlandK Overbeck, J F Dufour, B Müllhaupt, et al.
The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.
HIV Medicine|September 25, 2012
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort StudyR Weber, M Ruppik, M Rickenbach, et al.
British Journal of Cancer|July 31, 2008
Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapyS Franceschi, L Dal Maso, M Rickenbach, et al.
Pageof 9